Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 4/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | CNR1 | P21554 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.49 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.49 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.49 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | VNN1 | O95497 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29490805 | 0.89 | CNR2 (0.69) | CNR2NPSR1ALDH1A1HTTHPGD | |
| SCHEMBL194537 | 0.89 | CNR2 (0.69) | CNR2NPSR1ALDH1A1HTTHPGD | |
| SCHEMBL5606155 | 0.86 | CNR2 (0.66) | CNR2NPSR1ALDH1A1HTTHPGD | |
| SCHEMBL20783673 | 0.85 | MAPT (0.59) | NPSR1ALDH1A1HTTHPGDMAPT | |
| SCHEMBL29658753 | 0.83 | ATM (0.71) | CNR2ALDH1A1CNR1MAPTPOLB | |
| SCHEMBL81347 | 0.83 | ATM (0.71) | CNR2ALDH1A1CNR1MAPTPOLB | |
| SCHEMBL12906721 | 0.82 | CNR2 (0.65) | CNR2CNR1MAPTPOLBCTDSP1 | |
| SCHEMBL6019106 | 0.82 | CNR2 (0.69) | CNR2ALDH1A1CNR1MAPTPOLB | |
| SCHEMBL283198 | 0.82 | ATM (0.50) | CNR2NPSR1ALDH1A1HTTHPGD | |
| SCHEMBL822041 | 0.82 | PARP1 (0.63) | CNR2ALDH1A1HPGDCNR1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9564597-B2 | Fluorene compound, light-emitting element, light-emitting device, electronic device, lighting device, and organic compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-02-07 | — | — | US | disclosed |
| US-20150243899-A1 | Fluorene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-08-27 | — | — | US | disclosed |
| US-20120061714-A1 | Fluorene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150243899-A1 | Fluorene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Organic Compound | CYP1A1, CYP1B1, DRD1 | CNR2 605/4885NPSR1 1790/4885ALDH1A1 10/4885 |
| US-20120061714-A1 | Fluorene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Organic Compound | CYP1A1, CYP1B1, DRD1 | CNR2 605/4885NPSR1 1790/4885ALDH1A1 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.